The human cytokine interferon-inducible protein 10 (IP-10) is a small glycoprotein secreted by activated T cells, monocytes, endothelial cells, and keratinocytes, and is structurally related to a family of chemotactic cytokines called chemokines. Although this protein is present in sites of delayed-type hypersensitivity reactions and lepromatous leprosy lesions, the biological activity of IP-10 remains unknown. We report here that recombinant human IP-10 stimulated significant in vitro chemotaxis of human peripheral blood monocytes but not neutrophils. Recombinant human IP-10 also stimulated chemotaxis of stimulated, but not unstimulated, human peripheral blood T lymphocytes. Phenotypic analysis of the stimulated T cell population responsive to IP-10 demonstrated that stimulated CD4 + and CD29 + T cells migrated in response to IP-10. This resembles the biological activity of the previously described T cell chemoattractant R.ANTES. Using an endothelial cell adhesion assay, we demonstrated that stimulated T cells pretreated with optimal doses of IP-10 exhibited a greatly enhanced ability to bind to an interleukin 1-treated endothelial cell monolayer. These results demonstrate that the IP-10 gene encodes for an inflammatory mediator that specifically stimulates the directional migration of T cells and monocytes as well as potentiates T cell adhesion to endothelium.
T he accumulation of mononuclear cells at sites of antigenic challenge appears to be mediated by the local production and secretion of chemotactic cytokines. Several recently cloned cytokines constitute a family of chemotactic cytokines (chemokines) related by a conserved motif containing four cystdne residues (1) . IL-8, 3-thromboglobulin (/3-TG), platelet factor 4 (PF-4), GKO, ENA-78, and IFN-inducible protein 10 (IP-10) are members of the c~ (or c-x-c) chemokine family, while macrophage inflammatory protein 1 (MIP-1), RANTES, macrophage chemotactic and activating factor (MCAF), and 1-309 are included in the 3 (or c-c) chemokine part of the family. All but one of these cytokines have been found to induce the directional migration of various cell types, including neutrophils, monocytes, T lymphocytes, basophils, or fibroblasts, hence the recently proposed nomenclature "chemokines" for this cytokine family. Many of the c~ chemokine subfamily members, namely IL-8, GRO/melanoma growth-stimulating activity (MGSA), neutrophil-attracting peptide 2 (NAP-2), a cleavage product of 3-TG, and ENA-78, have been shown to chemoattract and activate neutrophils (1, 2) . In contrast, many of the ff chemokine subfamily members, such as MCAF/macrophage chemotactic protein 1 (MCP-1), MIPlc~ and MIP-13, R.ANTES, and 1-309, chemoattract and activate monocytes while RANTES and IL-8 also chemoattract T lymphocytes (3) (4) (5) . In addition, we have recently demonstrated that MIP-lc~ and MIP-13 are potent T cell chemoattractants (6) .
The human gene for IP-10 was initially identified by its expression in IFN-treated monocytes (7) . Although it has been several years since the molecular cloning of the IP-10 gene (8, 9) , no biological function has yet been reported. The expression of IP-10 in lepromatous leprosy lesions (10) and in delayed-type hypersensitivity responses (11) suggests that this chemokine may play an important role in the generation of an immune response. To gain insight into the physiological importance of this chemokine, we have tested purified recombinant human (rh)IP-10 for T cell, monocyte, and neutrophil chemotactic activity. The results demonstrate that rhlP-10 is chemotactic for both monocytes and stimulated T cells, but unlike many of the other c~ chemokine subfamily members, has only weak chemotactic activity for neutrophils. In addition, stimulated, but not unstimulated, CD4 + and CD29 + T cells are chemoattracted by rhlP-10. Purified T cells treated with rhlP-10 also have an increased capacity to adhere to ILl-treated human umbilical vein endothelial ceils (HUVEC). Our results suggest that rhlP-10 may play an important role in regulating migration of T lymphocytes and monocytes towards sites of antigenic challenge.
Materials and Methods
Cells. PBMC were obtained from normal donors by leukapheresis. The donors had given informed consent. T ceils and T cell subsets were purified using previously described techniques (12) . Briefly, PBMC were passaged over FicoU-Hypaque to remove erythrocytes, granulocytes" and cellular debris. Small lymphocytes were obtained by sequential depletion of adherent cells in plastic flasks, B lymphocytes on nylon wool columns, and large granuhr lymphocytes by Percoll gradient centrifugation. This isolation procedure typically yielded >90% CD3 § -lymphocytes. For T cell subset isolation, lymphocyte preparations were washed twice in cold PBS and resuspended at 2-3 x 107 ceils/ml. Saturating concentrations of anti-CD4, anti-CDH, anti-CD45ILA, or anti-CD45KO were added to the T cell suspension for overnight incubation at 4~ Purified CD4 +, CD8 +, CD45RA + , and CD29 + lymphocytes were obtained through negative selection using goat anti-mouse-specific Fc beads (Advanced Magnetics, Cambridge, MA) to sdectively deplete the unfractionated T cell populations of particular T cell subsets as described previously (12) . This procedure routinely yielded a >94% purified T cell subpopulation. For antibody activation of T cells or T cell subsets, the T cell preparations were adjusted to a concentration of 5 x 106 cells/ml and cultured on tissue culture plates previously coated with a 10-gg/ml suspension of anti-CD3 mAb. The T cells were cultured for 6-8 h, harvested, and used in T cell chemotaxis assays.
Chemokines. Purified rhIP-10 was expressed in Escherichia coli and purified by K. Matsushima (Kanazawa University). rhKANTES was also expressed in E. coli and was purchased from Pepro Tech Inc. (Rocky Hill, NJ).
ChemotaxisAssay. Cell migration was evaluated by using a 48-well microchemotaxis chamber technique (13) with polycarbonate filters (5-gm pore size; Nudeopore Corp., Pleasanton, CA). In the monocyte and neutrophil chemotactic assays, cells and chemokines were resuspended in R.PMI 1640 containing 1% BSA at 106 cells/ml, and 50/A/well was applied to the upper chamber. N-FMLP (Sigma Chemical Co., St. Louis, MO) at 10-7 M was used as a positive control, and all responses and filters were assayed in triplicate. Migration was allowed to continue at 37~ for 30-60 rain. After the nonmigrating ceils were washed from the upper surface of the filters, migrating cells were fixed in methanol and stained with Diff-Quik, and the numbers of migrating cells in five highpowered fields were counted for each well. The results represent the average number of migrating cells per high-powered field (_+ SD).
T lymphocyte migration was quantitated by a modification of the Boyden chamber technique. Briefly, T cells were suspended at 107 cells/ml in R.PMI 1640 plus 0.5% FCS, and were placed in the top wells of a 48-well microchemotaxis chamber. The upper Interferon-inducible Protein 10 and lower wells were separated by a 5-gm pore size polycarbonate filter that separated the cells from the control and experimental samples in the bottom wells. All polycarbonate filters used in these experiments were coated with collagen type IV 1-2 h before use in the assay (6, 14) . The chambers were incubated for 4 h at 37~ in a 5% CO2 moist atmosphere, and the filters were prepared as already outlined. It should be noted that large clumps of T lymphocytes were observed migrating through the filter making enumeration of migrating T cells all,cult. The data are expressed as the number of countable cells per high-power field; however, this may represent a considerable underestimate of the total number of cells that migrated into or through the filter. The statistical significance of cell migration in response to various concentrations of chemokines was determined using a repeated measure one-way analysis of variance (ANOVA). Results of these calculations are listed in the legends of each figure.
Adhesion Assay. HUVEC were prepared by collagenase treatment of umbilical cords as previously described (15) . Endothelial cells at passage three or earlier were plated at 1.5 x 10 s cells/well onto gelatin-coated 24-well plates (Costar, Cambridge, MA) and cukured to confluence over 48 h. Before the adhesion assays HUVEC were washed once with RPMI 1640/5% FCS and then incubated in this medium for 6 h at 37~ with or without the addition of 10 ng/ml of rhIblc~.
The measurement of T cell adhesion was based upon the binding of SlCr-labeled T cells as previously described (16) . Briefly, after preincubation, HUVEC were washed twice with medium (RPMI 1640/5~ FCS) and 500,000 SlCr-labeled T cells were added to each well in a final volume of 500 gl. The plates were incubated at 37~ for 60 rain and then washed three times with prewarmed medium using a standardized wash procedure. The contents of each well were lysed with 300 IA of 1% Triton X-100 and 3, emissions counted. Wells were inspected before lysis to ensure that the integrity of the HUVEC monolayer had been maintained. Total counts added and spontaneously released were determined for each variable in the assays.
Percentage adhesion was calculated according to the following formula: percentage adhesion = 100 x [measured cpm/(total cpm -spontaneously released cpm)]. The statistical significance of these results was determined using an unpaired student's t test.
Results

Purified rhlP-lO Is Chemotactic for Stimulated but Not Unstimulated Human T LTmphocytes.
The results (Fig. 1) demonstrate that stimulated T lymphocytes consistendy responded to concentrations of IP-10 ranging from 1 to 10 ng/ml. Higher concentrations (>--25 ng/ml) demonstrated litde or no reproducible activity on T cells, thus yielding the typical "bellshaped" chemotaxis dose-response curve, tLANTES induced significandy higher T ceil migration at similar concentrations. Unstimulated T cells ordy exhibited migratory activity to R.ANTES but not to IP-10.
The Effect of Human IP-IO on the Chemotactic Response of
Subsets of Stimulated CD4 +, CD8 +, CD29 +, and CD45RA + T Lymphocytes. Since RANTES has been reported to be a sdective chemoattractant for memory CD4 + T cells (5), the effects of rhlP-10 on subsets of T lymphocytes were investigated. The phenotypic characteristics of chemotactic T lymphocytes were determined through the use of negative sdection to enrich for T cell subpopulations. The results ( IP-10 (Fig. 3) . Unstimulated naive and memory T cell populations failed to respond to IP-10, but both subsets were chore 9 by RANTES. RANTES 
2) show significant migration of anti-CD3-stimulated but not unstimulated CD4 + T cells to rhlP-10. However, RANTES induced significantly more migration of CD4 + T cells regardless of the activation state. Further fractionation of T lymphocytes into naive (CD-45RA +) and memory (CD29 +) T cell subsets revealed that both stimulated CD451LA + and CD29 + cells migrated to RANTES, while only stimulated CD29 + T cells migrated significantly in response to
Effect of rhlP-lO on T Cell Adhesion to IL-I-treated HUVEC.
Peripheral blood T cells were pretreated with various concentrations ofrhIP-10 and RANTES at 37~ for 6 h on uncoated or anti-CD3 antibody-coated plates. After washing, lymphocytes were incubated with human umbilical vein endothdium that has been pretreated with an optimal concentration of rhIL-lol for the binding assay. The results shown in Fig. 5 demonstrate that rhlP-10 and rhRANTES at a concentration of 10 ng/ml were equipotent in augmenting adhesion of activated but not resting T lymphocytes to IL-l-treated endothelium.
Discussion
Our findings that rhlP-10 is chemotactic for stimulated but not unstimulated T lymphocytes are novel. Our data demonstrate that rhlP-10, like RANTES, is also a monocyte chemoattractant. Both chemokines attract monocytes at similar dose ranges and possess little activity on neutrophils. Although compared with rhRANTES the effect on T cell chemotaxis by IP-10 is modest, the more potent effects of rhlP-10 on T cell adhesion may reflect the fact that endothelial cells are IP-10 producers and suggest that it may play an important role in the entry of T lymphocytes into inflammatory rites and sites of delayed-type hypersensitivity. IP-10, like RANTES, also appears to selectively recruit and activate specific T cell subsets, rhIP-10 induced significant migratory activity in stimulated CD4 + and CD29 + T lymphocytes, while stimulated and unstimulated CD4 + as well as stimulated CD8 +, CD45RA +, and CD29 + T ceils migrated in response to rhRANTES. The activity of IP-10 appears to be dependent on the activation state of a T cell population and, in contrast to RANTES, unstimulated T lymphocytes were not affected by rhlP-10. These results suggest that IP-10 and RANTES are not redundant in their actions but play different roles attracting T lymphocytes to inflammatory sites. T cell adhesion to endothdial cells is necessary for the development of inflammatory and immunological responses. Immobilization of T cells on endothelial cells is required for recruitment of recirculating T cells from the vascular compartment, followed by transendothelial migration of T cells into tissues (17) . Cell-cell contact is necessary for specific immunological recognition by T cells of antigen presented by endothelial ceils and other accessory ceils in the context of MHC molecules (17) (18) (19) . Immunological mediators such as IFN-3,, TNF-c~, and IL-1 have been shown to promote these functions (17) (18) (19) . Our findings suggest that the T cell/monocyte chemoattractants, IP-10 as well as MIP-lc~, MIP-1B, and RANTES (6) , are all able to augment the T cell component of these phenomena, namely adhesion. Purified T cells triggered through the TCR complex with fixed anti-CD3 mAb in the presence of rhlP-10 or rhRANTES resulted in an increased adhesion to IL-l-treated endothelium when compared with control T cell populations. We did not detect alteration in surface expression of adhesion molecules on the T cell after IP-10 pretreatment. No alteration in the level of surface expression of LFA-1, VLA-3, VLA-4, VLA-5, VLA-6, CD44, intercellular adhesion molecule 1, vascular cell adhesion molecule, and endothelial leukocyte adhesion molecule (ELAM) was observed (data not shown). Changes in the conformational states of LFA-1 on T cells, Mac-1 on neutrophils, and ELAM-1 on endothelium have been implicated in regulatory adhesive phenomena (16) (17) (18) (19) , and raise the possibility that IP-10 may work through this or a similar mechanism. We suggest that IP-10 may have an important role in vivo in promoting endothelial cell-lymphocyte interactions and subsequent transmigration of T cells, monocytes, and possibly neutrophils in various inflammatory states. Recent data supporting this hypothesis were communicated by Dr. Andrew Luster (20) , demonstrating that mice injected with tumor cells transfected with the IP-10 gene exhibited a protective antitumor effect that appeared to require the presence of T cells.
